Insilico studies of Indenopyrazole Derivatives for Cancer

Drug discovery and drug design
 
 
LAP Lambert Academic Publishing
  • erschienen am 13. Januar 2018
 
  • Buch
  • |
  • Softcover
  • |
  • 68 Seiten
978-613-3-99393-8 (ISBN)
 
Indenopyrazoles are the novel drugs used to treat cancer. An insilico study has been performed to understand the most active analogue by 3D QSAR methods by the implication of CoMFA and CoMSIA studies which would help us to predict the activity of the drug. Docking studies has also been performed to determine the interaction of the analogues. In this book, a brief study of the indenopyrazole and its analogues has been done. This study aims to design a QSAR model by which a new analogue can be developed which on further study could act as a potent cdk4 inhibitor to treat cancer.
  • Englisch
  • Höhe: 220 mm
  • |
  • Breite: 150 mm
  • |
  • Dicke: 4 mm
  • 118 gr
978-613-3-99393-8 (9786133993938)
6133993936 (6133993936)
Pharmaceutical chemistry (M.Pharmacy) from JNTUH, Hyderabad. Pursued P.G Diploma in Bioinformatics from Osmania University, Hyderabad, Telangana, India and Bachelors in Pharmacy Degree from JNTUH, Hyderabad, Telangana, India. Have overall of three research publications each in EJPMR, IJPSDR and IAJPS respectively. Have keen interest in Drug Design.

Sofort lieferbar

35,90 €
inkl. 7% MwSt.
in den Warenkorb

Abholung vor Ort? Sehr gerne!
Unsere Web-Seiten verwenden Cookies. Mit der Nutzung dieser Web-Seiten erklären Sie sich damit einverstanden. Mehr Informationen finden Sie in unserem Datenschutzhinweis. Ok